FORMULARY DECISION
Empagliflozin + Metformin : Synjardy
1092/15 : In adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control / in patients inadequately controlled on their maximally toler...